185 related articles for article (PubMed ID: 25058038)
1. Comparison of the effects of CORM-2, CORM-3 and CORM-A1 on coagulation in human plasma.
Nielsen VG; Garza JI
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):801-5. PubMed ID: 25058038
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
[TBL] [Abstract][Full Text] [Related]
3. Carbon monoxide releasing molecule-2 enhances α2-antiplasmin activity.
Malayaman SN; Cohen JB; Machovec KA; Bernhardt BE; Arkebauer MR; Nielsen VG
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):345-8. PubMed ID: 21330914
[TBL] [Abstract][Full Text] [Related]
4. Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in human plasma.
Nielsen VG; Kirklin JK; George JF
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):377-80. PubMed ID: 19417630
[TBL] [Abstract][Full Text] [Related]
5. Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in subjects exposed to warfarin.
Nielsen VG; Khan ES; Kirklin JK; George JF
Thromb Res; 2010 Jul; 126(1):68-73. PubMed ID: 20406708
[TBL] [Abstract][Full Text] [Related]
6. The antifibrinolytic effects of carbon monoxide-releasing molecule-2 are fibrin and alpha2-antiplasmin dependent.
Nielsen VG
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):584-7. PubMed ID: 20683324
[TBL] [Abstract][Full Text] [Related]
7. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in human plasma.
Nielsen VG; Kirklin JK; George JF
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):448-55. PubMed ID: 19581800
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen is a heme-associated, carbon monoxide sensing molecule: a preliminary report.
Nielsen VG; Cohen JB; Malayaman SN; Nowak M; Vosseller K
Blood Coagul Fibrinolysis; 2011 Jul; 22(5):443-7. PubMed ID: 21451399
[TBL] [Abstract][Full Text] [Related]
9. Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in hemophilia A, hemophilia B and factor VII-deficient plasmas.
Nielsen VG; Kirklin JK; George JF
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):41-5. PubMed ID: 19923981
[TBL] [Abstract][Full Text] [Related]
10. Carbon monoxide releasing molecule-2 attenuates the anticoagulant and amplifies the hypofibrinolytic effects of hypothermia in human plasma in vitro.
Nielsen VG; George SJ
Blood Coagul Fibrinolysis; 2011 Jan; 22(1):67-72. PubMed ID: 21157299
[TBL] [Abstract][Full Text] [Related]
11. The procoagulant properties of purified fibrinogen concentrate are enhanced by carbon monoxide releasing molecule-2.
Machovec KA; Ushakumari DS; Welsby IJ; Nielsen VG
Thromb Res; 2012 Jun; 129(6):793-6. PubMed ID: 21872302
[TBL] [Abstract][Full Text] [Related]
12. Redox-based thrombelastographic method to detect carboxyhemefibrinogen-mediated hypercoagulability.
Nielsen VG; Arkebauer MR; Vosseller K
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):657-61. PubMed ID: 21822126
[TBL] [Abstract][Full Text] [Related]
13. Carbon monoxide releasing molecule-2 improves protamine-mediated hypocoagulation/hyperfibrinolysis in human plasma in vitro.
Nielsen VG; Malayaman SN; Cohen JB; Persaud JM
J Surg Res; 2012 Apr; 173(2):232-9. PubMed ID: 20950825
[TBL] [Abstract][Full Text] [Related]
14. Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in plasma exposed to heparin or argatroban.
Nielsen VG; Khan ES; Kirklin JK; George JF
Anesth Analg; 2010 Dec; 111(6):1347-52. PubMed ID: 21048101
[TBL] [Abstract][Full Text] [Related]
15. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in vitro and in vivo in the rabbit.
Nielsen VG; Arkebauer MR; Wasko KA; Malayaman SN; Vosseller K
Blood Coagul Fibrinolysis; 2012 Jan; 23(1):104-7. PubMed ID: 22143252
[TBL] [Abstract][Full Text] [Related]
16. Carbon monoxide releasing molecule-2 enhances coagulation and attenuates fibrinolysis by two mechanisms: insights gained with colloid dilution.
Cohen JB; Persaud JM; Malayaman SN; Nielsen VG
Blood Coagul Fibrinolysis; 2011 Jan; 22(1):60-6. PubMed ID: 21157300
[TBL] [Abstract][Full Text] [Related]
17. Carbon monoxide-releasing molecule-2 enhances coagulation in rabbit plasma and decreases bleeding time in clopidogrel/aspirin-treated rabbits.
Nielsen VG; Chawla N; Mangla D; Gomes SB; Arkebauer MR; Wasko KA; Sadacharam K; Vosseller K
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):756-9. PubMed ID: 22008906
[TBL] [Abstract][Full Text] [Related]
18. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule.
Motterlini R; Sawle P; Hammad J; Bains S; Alberto R; Foresti R; Green CJ
FASEB J; 2005 Feb; 19(2):284-6. PubMed ID: 15556971
[TBL] [Abstract][Full Text] [Related]
19. Carbon Monoxide-Releasing Molecule Enhances Coagulation and Decreases Fibrinolysis in Normal Canine Plasma.
Donaghy D; Yoo S; Johnson T; Nielsen V; Olver C
Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):257-262. PubMed ID: 29577635
[TBL] [Abstract][Full Text] [Related]
20. Freezing does not decrease carbon monoxide-mediated hypercoagulation and hypofibrinolysis in human plasma.
Nielsen VG; Hafner DT
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):784-6. PubMed ID: 22964769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
